These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8185647

  • 1. Modulation by superoxide anions of neutrophil-mediated platelet activation.
    Renesto P, Si Tahar M, Chignard M.
    Biochem Pharmacol; 1994 Apr 20; 47(8):1401-4. PubMed ID: 8185647
    [Abstract] [Full Text] [Related]

  • 2. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
    Renesto P, Balloy V, Chignard M.
    Eur J Pharmacol; 1993 Aug 02; 248(2):151-5. PubMed ID: 8223961
    [Abstract] [Full Text] [Related]

  • 3. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
    Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C.
    Blood; 1991 Jun 01; 77(11):2379-88. PubMed ID: 1645603
    [Abstract] [Full Text] [Related]

  • 4. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M.
    Am J Physiol; 1990 Jun 01; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
    Renesto P, Chignard M.
    Blood; 1993 Jul 01; 82(1):139-44. PubMed ID: 8324217
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
    Renesto P, Balloy V, Kamimura T, Masuda K, Imaizumi A, Chignard M.
    Br J Pharmacol; 1993 Apr 01; 108(4):1100-6. PubMed ID: 8097952
    [Abstract] [Full Text] [Related]

  • 7. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
    Renesto P, Chignard M.
    J Lab Clin Med; 1994 Jun 01; 123(6):906-13. PubMed ID: 8201270
    [Abstract] [Full Text] [Related]

  • 8. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
    Renesto P, Ferrer-Lopez P, Chignard M.
    Lab Invest; 1990 Apr 01; 62(4):409-16. PubMed ID: 2159081
    [Abstract] [Full Text] [Related]

  • 9. Protease-modulation of neutrophil superoxide response.
    Kusner DJ, King CH.
    J Immunol; 1989 Sep 01; 143(5):1696-702. PubMed ID: 2547873
    [Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
    Renesto P, Chignard M.
    J Immunol; 1991 Apr 01; 146(7):2305-9. PubMed ID: 2005399
    [Abstract] [Full Text] [Related]

  • 11. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH, Cheng JT, Teng CM.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):158-67. PubMed ID: 16112105
    [Abstract] [Full Text] [Related]

  • 12. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T, Meyer-Hoffert U, Schröder JM, Wiedow O.
    Exp Dermatol; 2004 May 05; 13(5):316-25. PubMed ID: 15140022
    [Abstract] [Full Text] [Related]

  • 13. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.
    Evangelista V, Piccardoni P, de Gaetano G, Cerletti C.
    Thromb Haemost; 1992 Jun 01; 67(6):660-4. PubMed ID: 1509406
    [Abstract] [Full Text] [Related]

  • 14. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
    Ferrer-Lopez P, Renesto P, Prevost MC, Gounon P, Chignard M.
    J Lab Clin Med; 1992 Mar 01; 119(3):231-9. PubMed ID: 1541873
    [Abstract] [Full Text] [Related]

  • 15. Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine.
    Renesto P, Balloy V, Vargaftig BB, Chignard M.
    Br J Pharmacol; 1991 Jun 01; 103(2):1435-40. PubMed ID: 1653073
    [Abstract] [Full Text] [Related]

  • 16. LTB4 induced activation signals and responses in neutrophils are short-lived compared to formylpeptide.
    Omann GM, Traynor AE, Harris AL, Sklar LA.
    J Immunol; 1987 Apr 15; 138(8):2626-32. PubMed ID: 3031161
    [Abstract] [Full Text] [Related]

  • 17. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.
    Rajtar G, Marchi E, de Gaetano G, Cerletti C.
    Biochem Pharmacol; 1993 Sep 01; 46(5):958-60. PubMed ID: 8373448
    [Abstract] [Full Text] [Related]

  • 18. Eglin C and heparin inhibition of platelet activation induced by cathepsin G or human neutrophils.
    Renesto P, Ferrer-Lopez P, Chignard M.
    Ann N Y Acad Sci; 1991 Sep 01; 624():321-4. PubMed ID: 2064235
    [No Abstract] [Full Text] [Related]

  • 19. Superoxide production of human polymorphonuclear leukocytes stimulated by leukotriene B4.
    Sumimoto H, Takeshige K, Minakami S.
    Biochim Biophys Acta; 1984 Apr 16; 803(4):271-7. PubMed ID: 6322859
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms for lipoxin A4 induced neutrophil dependent cytotoxicity for human endothelial cells.
    Bratt J, Lerner R, Ringertz B, Palmblad J.
    Adv Prostaglandin Thromboxane Leukot Res; 1995 Apr 16; 23():419-21. PubMed ID: 7732886
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.